City Therapeutics gets $99M to gather data on three RNAi medicines

Andy Orth, City Therapeutics CEO June 8, 2026 02:26 PM EDTUpdated 02:49 PM FinancingStartups City Ther­a­peu­tics gets $99M to gath­er da­ta on three RNAi med­i­cines Kyle LaHucik Biotech Correspondent City Ther­a­peu­tics, the next-gen RNAi start­up found­ed and led by for­mer Al­ny­lam ex­ec­u­tives, has col­lect­ed $99.5 mil­lion to fund the clin­i­cal de­vel­op­ment of its first … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER